A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM
Clinical trial NCT07142161 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07142161
- Sponsor
- Nanjing Bioheng Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-20
- Primary completion
- 2026-07-24
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.